Skip to main content
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
OTCMKTS · Delayed Price · Currency is USD
1.945
+0.045 (2.37%)
At close: Mar 27, 2025

SFOSF Revenue

In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B CNY, down -0.80%. Shanghai Fosun Pharmaceutical (Group) had revenue of 10.16B in the quarter ending December 31, 2024, a decrease of -5.09%.

Revenue
41.07B CNY
Revenue Growth
-0.80%
P/S Ratio
1.43
Revenue / Employee
1.01M CNY
Employees
40,557
Market Cap
8.04B USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News